{
 "context": "The following article called 'Study Finds Differences in 2 Cholesterol-Lowering Drugs' was published on 2003-11-12. The body of the article is as follows:\n    \n The first study to compare two powerful cholesterol-lowering drugs head-to-head in coronary artery disease finds one clearly superior. Patients taking the highest available dose of pravastatin, or Pravachol, made by Bristol-Myers Squibb, had slowly progressing atherosclerosis over an 18-month period. But the disease was halted in those who took the highest dose of atorvastatin, or Lipitor, the drug made by Pfizer. \n\n    The day before the article was published, the stock price of Bristol-Myers Squibb Company was 12.635136604309082 and the day after the article was published, the stock price of Bristol-Myers Squibb Company was ",
 "expected": "13.130834579467773",
 "date": "2003-11-12",
 "ticker": "BMY",
 "company": "Bristol-Myers Squibb Company",
 "url": "https://www.nytimes.com/2003/11/12/health/study-finds-differences-in-2-cholesterollowering-drugs.html"
}